FDA Approvals in Oncology: January-March 2025
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
Author:
Cancer Research Catalyst Staff
In the first quarter of 2025, the FDA issued 13 approvals for oncology treatments, covering nine types of cancer...
This month, the editors of AACR's journals tout studies showcasing the immunostimulatory impact of senescent cancer cells, a novel...
This month, the editors of AACR's journals show their love for studies about CAR T-cell efficacy, breast cancer risk,...
As World Cancer Day 2025 focuses on being "United by Unique," AACR shares how its initiatives help to connect...
This quarterly series on creative approaches to cancer research includes urine-powered nanomotors, unique molds to grow organoids, and more.
As winter marches on, let’s dive into the cool articles highlighted this month by the editors of the AACR...
In the final three months of 2024, the FDA issued 15 approvals in oncology, including several therapies that are...
This month, the editors of the AACR journals highlighted studies about the gut microbiome in lung cancer, modeling the...
What did we learn about cancer in 2024? How did research advance our understanding of cancer? What new approvals...
As we head into the holiday season, Cancer Research Catalyst has tantalizing teasers in the form of science stocking...